Ethicon paid $3.4 billion in cash and may pay an additional $2.35 billion if certain milestones are achieved.
The acquisition of Auris Health’s robotic technology, which is used in diagnostic and therapeutic lung procedures, fuels Johnson & Johnson’s efforts to improve surgical care and lung cancer intervention.
As part of that aim, Johnson & Johnson is developing robotic technologies for general surgery through a collaboration with Verily and expanded its orthopedic portfolio by acquiring Orthotaxy.
More articles on devices:
Washington Orthopaedic Center expanding in new location — 3 insights
Ohio Sports & Spine Institute opens new location — 3 insights
Baptist Health hiring ASC director for Miami Heat development — 3 key insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
